Online Webinar 2019 - Sterile Filtration of Pharmaceutical Products - What you need to know to meet Validation and Regulatory Requirements
Topics/Call fo Papers
Overview
This webinar will include a detailed discussion of Contract Manufacturing Organizations (CMO) Quality Agreement topics such as change control, documentation, facilities and equipment, lab controls, sub-contracting, etc. Attendees will learn how to comply with new FDA and EU guidelines for contract drug manufacturers.
Why Should You Attend
Control of suppliers such as Contract Manufacturing Organizations (CMO) has always been a requirement of the FDA and EU. With the issuance of these new regulatory documents the expectation is that there will be a written documentation of this control. Proof of this control can be presented to FDA / EU inspectors in the form of a Quality Agreement which is specific to a particular CMO.
This webinar will provide a thorough understanding of the content that is expected in Quality Agreements from a regulatory perspective. Each proposed section of a Quality Agreement is fully analyzed and suggested content is written with the new guidelines taken into consideration. Comparison of the two regulatory documents will be presented with differences highlighted and discussed. The latest status of the FDA draft guidance will be discussed and a review of comments from industry is included.
Session Highlights
The who and what of a good Quality Agreement
What a Quality Agreement is - and is not
Responsibilities of the owner vs. contract facility
GMP responsibilities
A comparison of the new guidelines from the FDA and the EU
Who Will Benefit:
This webinar will provide valuable assistance to all personnel in:
Quality Assurance
External Manufacturing / Outsourcing
Quality Auditing
Technology Transfer
Regulatory Affairs / Compliance
Supply Chain
Purchasing
Risk Management
Speaker Profile
Roger Cowan, is the founder and owner of R Cowan Consulting Services LLC, a consulting company specializing primarily in the area of pharmaceutical contract manufacturing. He has 35 years’ experience in pharmaceutical quality assurance and manufacturing. In his career, Roger has held various manager / director positions in Quality Assurance, QC Laboratory, Technical Services Validation, Manufacturing, and Clinical Supply manufacturing and distribution. Roger has taught courses in microbiology at Seneca College (Pharmaceutical Technology Program) in Toronto, Canada.
Roger's areas of expertise include: aseptic pharmaceutical manufacture, GMP facility audits, technical transfer, microbiology, environmental monitoring/contamination control, product sterilization, process development, process validation, clinical supply manufacturing, labeling and distribution, US / International regulatory requirements, regulatory submissions, and quality assurance/control.
This webinar will include a detailed discussion of Contract Manufacturing Organizations (CMO) Quality Agreement topics such as change control, documentation, facilities and equipment, lab controls, sub-contracting, etc. Attendees will learn how to comply with new FDA and EU guidelines for contract drug manufacturers.
Why Should You Attend
Control of suppliers such as Contract Manufacturing Organizations (CMO) has always been a requirement of the FDA and EU. With the issuance of these new regulatory documents the expectation is that there will be a written documentation of this control. Proof of this control can be presented to FDA / EU inspectors in the form of a Quality Agreement which is specific to a particular CMO.
This webinar will provide a thorough understanding of the content that is expected in Quality Agreements from a regulatory perspective. Each proposed section of a Quality Agreement is fully analyzed and suggested content is written with the new guidelines taken into consideration. Comparison of the two regulatory documents will be presented with differences highlighted and discussed. The latest status of the FDA draft guidance will be discussed and a review of comments from industry is included.
Session Highlights
The who and what of a good Quality Agreement
What a Quality Agreement is - and is not
Responsibilities of the owner vs. contract facility
GMP responsibilities
A comparison of the new guidelines from the FDA and the EU
Who Will Benefit:
This webinar will provide valuable assistance to all personnel in:
Quality Assurance
External Manufacturing / Outsourcing
Quality Auditing
Technology Transfer
Regulatory Affairs / Compliance
Supply Chain
Purchasing
Risk Management
Speaker Profile
Roger Cowan, is the founder and owner of R Cowan Consulting Services LLC, a consulting company specializing primarily in the area of pharmaceutical contract manufacturing. He has 35 years’ experience in pharmaceutical quality assurance and manufacturing. In his career, Roger has held various manager / director positions in Quality Assurance, QC Laboratory, Technical Services Validation, Manufacturing, and Clinical Supply manufacturing and distribution. Roger has taught courses in microbiology at Seneca College (Pharmaceutical Technology Program) in Toronto, Canada.
Roger's areas of expertise include: aseptic pharmaceutical manufacture, GMP facility audits, technical transfer, microbiology, environmental monitoring/contamination control, product sterilization, process development, process validation, clinical supply manufacturing, labeling and distribution, US / International regulatory requirements, regulatory submissions, and quality assurance/control.
Other CFPs
- Fired by Facebook - HIPAA and social media violations of HIPAA’s privacy requirements
- Pharma curriculum development using a Learning Management System (LMS) Live Webinar
- Writing Effective SOPs for the Medical Device and Pharmaceutical Industries
- 21 CFR Part 11, SaaS/Cloud, EU GDPR Live Webinar
- Live Webinar A Bulletproof, Cost-Efficient Supplier Management Program
Last modified: 2019-05-03 20:40:10